Cargando…
Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen b...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349202/ https://www.ncbi.nlm.nih.gov/pubmed/30484953 http://dx.doi.org/10.1111/jcmm.14047 |
_version_ | 1783390237052895232 |
---|---|
author | Cao, Rang‐Juan Li, Kai Xing, Wan‐Ying Du, Shuang Li, Qiang Zhu, Xiao‐Juan Cui, Shu‐Sen |
author_facet | Cao, Rang‐Juan Li, Kai Xing, Wan‐Ying Du, Shuang Li, Qiang Zhu, Xiao‐Juan Cui, Shu‐Sen |
author_sort | Cao, Rang‐Juan |
collection | PubMed |
description | Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF‐κB/Bcl‐2/caspase‐9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer. |
format | Online Article Text |
id | pubmed-6349202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63492022019-02-01 Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 Cao, Rang‐Juan Li, Kai Xing, Wan‐Ying Du, Shuang Li, Qiang Zhu, Xiao‐Juan Cui, Shu‐Sen J Cell Mol Med Short Communications Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF‐κB/Bcl‐2/caspase‐9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer. John Wiley and Sons Inc. 2018-11-28 2019-02 /pmc/articles/PMC6349202/ /pubmed/30484953 http://dx.doi.org/10.1111/jcmm.14047 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communications Cao, Rang‐Juan Li, Kai Xing, Wan‐Ying Du, Shuang Li, Qiang Zhu, Xiao‐Juan Cui, Shu‐Sen Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title | Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title_full | Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title_fullStr | Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title_full_unstemmed | Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title_short | Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 |
title_sort | disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through nf‐κb/bcl‐2/caspase‐9 |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349202/ https://www.ncbi.nlm.nih.gov/pubmed/30484953 http://dx.doi.org/10.1111/jcmm.14047 |
work_keys_str_mv | AT caorangjuan disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT likai disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT xingwanying disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT dushuang disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT liqiang disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT zhuxiaojuan disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 AT cuishusen disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9 |